(Q33438688)

26 July 2017

Characterization of PF4-Heparin Complexes by Photon Correlation Spectroscopy and Zeta Potential (English)

1 reference

26 July 2017

Sabrina Bertini

1

1 reference

26 July 2017

Jawed Fareed

2

1 reference

26 July 2017

Laura Madaschi

3

1 reference

26 July 2017

Giulia Risi

4

1 reference

26 July 2017

Giangiacomo Torri

5

1 reference

26 July 2017

Annamaria Naggi

6

1 reference

26 July 2017

1 January 2017

1 reference

Clinical and Applied Thrombosis-Hemostasis

26 July 2017

1 reference

26 July 2017

1076029616685430

1 reference

Heparin induced thrombocytopenia: diagnosis and management update

26 July 2017

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Human platelet factor 4 monomer-dimer-tetramer equilibria investigated by 1H NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Heparin dodecasaccharide binding to platelet factor-4 and growth-related protein-alpha. Induction of a partially folded state and implications for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Characterisation of the conformational changes in platelet factor 4 induced by polyanions: towards in vitro prediction of antigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Determinants of PF4/heparin immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

A nanosensor for ultrasensitive detection of oversulfated chondroitin sulfate contaminant in heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1076029616685430

21 January 2018

Identifiers

DOI

10.1177/1076029616685430

1 reference

26 July 2017

1 reference